Computational platform Schrödinger is leveraging Google Cloud to advance drug screening and identify potentially viable molecules. “We’re excited to harness Google Cloud’s highly scalable system to run extensive free energy calculations to assess binding affinities through our compute-intensive FEP+ application. This partnership also enables us to further leverage BigQuery to analyze important molecular properties nearly instantaneously,” said Shane Brauner, Schrödinger’s Chief Information Officer. Yourway supports advanced efforts in drug discovery and has an impressive global logistics network in place to help new drugs reach clinical trials.